Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
FP14 - Targeted Therapy - Clinically Focused
- Type: Posters (Featured)
- Track: Targeted Therapy - Clinically Focused
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP14.09 - Tepotinib Safety in MET Exon 14 (METex14) Skipping NSCLC: Updated Results from the VISION Trial
00:00 - 00:00 | Presenter: Rémi Veillon
- Abstract
Loading...
-
+
OA04 - New Data from Rare EGFR Alterations
- Type: Oral
- Track: Targeted Therapy - Clinically Focused
- Presentations: 8
- Coordinates: 1/29/2021, 11:45 - 12:45, Scientific Program Auditorium
-
+
OA04.05 - Trastuzumab Deruxtecan in HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Interim Results of DESTINY-Lung01
12:05 - 12:15 | Presenter: Kazuhiko Nakagawa
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA11 - Expanding Targetable Genetic Alterations in NSCLC
- Type: Mini Oral
- Track: Targeted Therapy - Clinically Focused
- Presentations: 12
- Coordinates: 1/31/2021, 14:15 - 15:15, Scientific Program Auditorium
-
+
MA11.03 - Trastuzumab Deruxtecan in HER2-Mutated Metastatic Non-Small Cell Lung Cancer (NSCLC): Interim Results of DESTINY-Lung01
14:15 - 14:20 | Presenter: Egbert F Smit
- Abstract
Loading... -
+
MA11.05 - Tepotinib in Patients with MET exon 14 (METex14) Skipping Advanced NSCLC: Updated Efficacy Results from VISION Cohort A
14:25 - 14:30 | Presenter: Paul K. Paik
- Abstract
Loading...